Sales 2024 * | 4.9TCr 4.54TCr 4,08600Cr | Sales 2025 * | 5.08TCr 4.71TCr 4,23900Cr | Capitalization | 21TCr 19TCr 17,47800Cr |
---|---|---|---|---|---|
Net income 2024 * | 1.05TCr 973.33Cr 88TCr | Net income 2025 * | 1.21TCr 1.12TCr 1,00700Cr | EV / Sales 2024 * | 4.54 x |
Net Debt 2024 * | 1.29TCr 1.19TCr 1,07500Cr | Net Debt 2025 * | 1.13TCr 1.05TCr 94TCr | EV / Sales 2025 * | 4.35 x |
P/E ratio 2024 * |
19.9
x | P/E ratio 2025 * |
17.1
x | Employees | 76,057 |
Yield 2024 * |
3.55% | Yield 2025 * |
3.68% | Free-Float | 85.22% |
Latest transcript on Novartis AG
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 48 | 01/05/01 | |
Director of Finance/CFO | 59 | 01/03/01 | |
Shreeram Aradhye
CTO | Chief Tech/Sci/R&D Officer | 62 | 16/22/16 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bill Winters
BRD | Director/Board Member | 62 | 01/13/01 |
Simon Moroney
BRD | Director/Board Member | 65 | 28/20/28 |
Chairman | 68 | 01/13/01 |
1st Jan change | Capi. | |
---|---|---|
+30.03% | 68TCr | |
+30.34% | 57TCr | |
-3.92% | 36TCr | |
+18.03% | 33TCr | |
+4.27% | 28TCr | |
+16.21% | 24TCr | |
-6.83% | 20TCr | |
+7.01% | 17TCr | |
-1.41% | 16TCr |